Library — CHDR

Search

Filter

Safety, tolerability and pharmacokinetic characterisation of DACRA KBP-042 in healthy male subjects.

Henriksen K, Broekhuizen K, de Boon WMI, Karsdal MA, Bihlet AR, Christiansen C, Dillingh MR, de Kam M, Kumar R, Burggraaf K, Kamerling IMC

British journal of clinical pharmacology, 2021 May

View publication
Intronic Haplotypes in GBA Modify Age at Diagnosis of Parkinson's: Replication in a Subgroup

Justin M. O'Sullivan, Jonas M. den Heijer, Geert J. Groeneveld, Antony A. Cooper

Movement disorders, 2021 May

View publication
Postdischarge Recovery after Acute Pediatric Lung Disease Can Be Quantified with Digital Biomarkers.

Kruizinga MD, Moll A, Zhuparris A, Ziagkos D, Stuurman FE, Nuijsink M, Cohen AF, Driessen GJA

Respiration; international review of thoracic diseases, 2021 May

View publication
Using machine learning techniques to characterize sleep-deprived driving behavior.

van der Wall HEC, Doll RJ, van Westen GJP, Koopmans I, Zuiker RG, Burggraaf J, Cohen AF

Traffic injury prevention, 2021 May

View publication
Good Clinical Trials by removing defensive interpretation of Good Clinical Practice guidelines

Jonas M. den Heijer, Jules A. A. C. Heuberger, Hemme Hijma, Annelieke C. Kruithof, Jeroen van Smeden, Geert Jan Groeneveld, Jacobus Burggraaf, Adam Cohen

Brit Jnl Clinical Pharma. , 2021 May

View publication
Development and Technical Validation of a Smartphone-Based Cry Detection Algorithm.

ZhuParris A, Kruizinga MD, van Gent M, Dessing E, Exadaktylos V, Doll RJ, Stuurman FE, Driessen GA, Cohen AF

Frontiers in pediatrics, 2021 May

View publication
Stability analysis of clustering of Norris' visual analogue scale: Applying the consensus clustering approach.

Guan Z, Chen XG, Hay J, van Gerven J, Burggraaf J, de Kam M

Medicine, 2021 Apr; 100(17):e25363

View publication
Phase 1 Clinical Trial of Losmapimod in Facioscapulohumeral Dystrophy (FSHD): Safety, Tolerability, Pharmacokinetics, and Target Engagement.

Mellion ML, Ronco L, Berends CL, Pagan L, Brooks S, van Esdonk MJ, van Brummelen EMJ, Odueyungbo A, Thompson LA, Hage M, Badrising UA, Raines S, Tracewell WG, van Engelen B, Cadavid D, Groeneveld GJ

British journal of clinical pharmacology, 2021 Apr

View publication
Effectiveness and tolerability of personalized omalizumab treatment in patients with chronic inducible urticaria.

Buters TP, van der Velden WAC, Abdisalaam I, van Maaren MS, van Doorn MBA

The journal of allergy and clinical immunology. In practice, 2021 Apr

View publication

«
1
2
...
4
5
6
7
8
9
10
...
85
86
»